Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Transport Proteins | 14 | 2025 | 78 | 5.910 |
Why?
|
| Anti-Bacterial Agents | 19 | 2023 | 523 | 4.260 |
Why?
|
| Gram-Negative Bacteria | 10 | 2022 | 62 | 3.710 |
Why?
|
| Bacterial Outer Membrane Proteins | 9 | 2025 | 101 | 3.100 |
Why?
|
| Pseudomonas aeruginosa | 7 | 2022 | 71 | 2.790 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 10 | 2025 | 29 | 2.550 |
Why?
|
| Escherichia coli Proteins | 7 | 2025 | 118 | 2.050 |
Why?
|
| Multidrug Resistance-Associated Proteins | 7 | 2025 | 19 | 1.720 |
Why?
|
| Acinetobacter baumannii | 4 | 2022 | 14 | 1.680 |
Why?
|
| Bacterial Proteins | 9 | 2022 | 485 | 1.600 |
Why?
|
| Escherichia coli | 5 | 2025 | 337 | 1.390 |
Why?
|
| Carrier Proteins | 4 | 2025 | 252 | 1.300 |
Why?
|
| Lipoproteins | 3 | 2025 | 99 | 1.270 |
Why?
|
| Biological Transport | 10 | 2023 | 122 | 1.100 |
Why?
|
| Cell Membrane | 3 | 2022 | 259 | 0.790 |
Why?
|
| Microbial Sensitivity Tests | 5 | 2022 | 148 | 0.780 |
Why?
|
| Porins | 3 | 2020 | 13 | 0.720 |
Why?
|
| Peptidomimetics | 1 | 2021 | 3 | 0.720 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2020 | 22 | 0.710 |
Why?
|
| Models, Biological | 2 | 2021 | 466 | 0.650 |
Why?
|
| Burkholderia | 1 | 2019 | 6 | 0.650 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 78 | 0.620 |
Why?
|
| Triclosan | 2 | 2020 | 2 | 0.580 |
Why?
|
| Genes, MDR | 1 | 2016 | 6 | 0.540 |
Why?
|
| ATP-Binding Cassette Transporters | 3 | 2018 | 38 | 0.420 |
Why?
|
| Molecular Docking Simulation | 3 | 2020 | 51 | 0.360 |
Why?
|
| Binding Sites | 3 | 2021 | 353 | 0.350 |
Why?
|
| Permeability | 2 | 2022 | 61 | 0.340 |
Why?
|
| Novobiocin | 2 | 2020 | 16 | 0.320 |
Why?
|
| Macromolecular Substances | 1 | 2009 | 53 | 0.320 |
Why?
|
| Membrane Fusion Proteins | 1 | 2008 | 2 | 0.310 |
Why?
|
| Erythromycin | 2 | 2020 | 15 | 0.300 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 42 | 0.290 |
Why?
|
| Gene Expression | 2 | 2021 | 417 | 0.270 |
Why?
|
| Protein Binding | 3 | 2025 | 658 | 0.240 |
Why?
|
| Magnesium | 1 | 2025 | 42 | 0.230 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 208 | 0.210 |
Why?
|
| Models, Molecular | 2 | 2025 | 452 | 0.210 |
Why?
|
| Phylogeny | 2 | 2019 | 479 | 0.200 |
Why?
|
| Drug Resistance, Multiple | 1 | 2002 | 20 | 0.200 |
Why?
|
| Drug Resistance, Microbial | 1 | 2021 | 36 | 0.180 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 4 | 0.180 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 6 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 25 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 51 | 0.180 |
Why?
|
| Cell Membrane Permeability | 2 | 2020 | 44 | 0.180 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 19 | 0.170 |
Why?
|
| Thermodynamics | 1 | 2021 | 93 | 0.170 |
Why?
|
| Klebsiella pneumoniae | 1 | 2020 | 29 | 0.170 |
Why?
|
| Burkholderia pseudomallei | 1 | 2019 | 3 | 0.160 |
Why?
|
| Drug Synergism | 1 | 2020 | 104 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 545 | 0.160 |
Why?
|
| Models, Statistical | 1 | 2020 | 128 | 0.160 |
Why?
|
| Protein Domains | 1 | 2019 | 52 | 0.150 |
Why?
|
| Computational Biology | 1 | 2020 | 155 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 40 | 0.150 |
Why?
|
| Humans | 6 | 2022 | 28094 | 0.150 |
Why?
|
| Substrate Specificity | 1 | 2018 | 151 | 0.140 |
Why?
|
| Burkholderia cepacia | 1 | 2017 | 5 | 0.140 |
Why?
|
| Diffusion | 1 | 2017 | 39 | 0.140 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2018 | 156 | 0.140 |
Why?
|
| Biological Transport, Active | 2 | 2009 | 17 | 0.140 |
Why?
|
| Arabinose | 1 | 2016 | 4 | 0.140 |
Why?
|
| Transformation, Bacterial | 1 | 2016 | 13 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2016 | 24 | 0.130 |
Why?
|
| Plasmids | 1 | 2016 | 126 | 0.130 |
Why?
|
| Vancomycin | 1 | 2016 | 58 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 413 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 343 | 0.120 |
Why?
|
| Mutation | 1 | 2019 | 845 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2008 | 484 | 0.100 |
Why?
|
| Models, Chemical | 1 | 2009 | 90 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2008 | 111 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 207 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 233 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 689 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1051 | 0.070 |
Why?
|
| Histidine | 1 | 2025 | 52 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 267 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2025 | 222 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2020 | 27 | 0.040 |
Why?
|
| Membrane Transport Modulators | 1 | 2020 | 3 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2020 | 34 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 230 | 0.040 |
Why?
|
| Animals | 1 | 2003 | 10415 | 0.020 |
Why?
|